News|Articles|November 20, 2023
Intact mass analysis of monoclonal antibody charge variants
Author(s)Thermo Fisher Scientific
This note demonstrates identification of Infliximab charge variants from intact mass analysis enabled by two-dimensional liquid chromatography
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Implications of the First Liquid IV Infliximab Biosimilar
2
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
3
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
4
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
5
